Literature DB >> 20865986

Clinical and genetic correlates of exercise performance in young children with cystic fibrosis.

Michael G McBride1, Joan I Schall, Babette S Zemel, Virginia A Stallings, Richard F Ittenbach, Stephen M Paridon.   

Abstract

Exercise performance in individuals with cystic fibrosis has been shown to be related to the extent of pulmonary dysfunction and undernutrition and genetic profile. The aim of this study was to examine these relationships in young children with cystic fibrosis. The participants were 64 children ages 8 to 11 years (M = 9.3, SD = 0.9) with cystic fibrosis and pancreatic insufficiency recruited from 13 different U.S. cystic fibrosis centers. Assigned to one of three groups by deltaF508 status: deltaF508/deltaF508 homozygous, deltaF508/Other heterozygous, and Other/Other, growth, nutritional and pulmonary status, and exercise performance were measured. Differences in exercise performance, pulmonary function, and nutritional status were not observed among the three groups. However, undernutrition and decreased pulmonary function were associated with measures of exercise performance. These results imply no effect of deltaF508 status on overall functional capacity during preadolescence in children with cystic fibrosis. Rather, the extent of pulmonary disease and undernutrition were associated with functional performance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865986      PMCID: PMC4480683          DOI: 10.2466/pms.110.C.995-1009

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  28 in total

1.  Long-term change in exercise capacity, body mass, and pulmonary function in adults with cystic fibrosis.

Authors:  A J Moorcroft; M E Dodd; A K Webb
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Factors limiting anaerobic performance in adolescent males with cystic fibrosis.

Authors:  S R Boas; M L Joswiak; P A Nixon; J A Fulton; D M Orenstein
Journal:  Med Sci Sports Exerc       Date:  1996-03       Impact factor: 5.411

4.  Some statistical methods for multiple endpoints in clinical trials.

Authors:  J Zhang; H Quan; J Ng; M E Stepanavage
Journal:  Control Clin Trials       Date:  1997-06

5.  Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening.

Authors:  F F Chehab; J Wall
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

6.  Determination of body composition of children from skinfold measurements.

Authors:  C G Brook
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

7.  Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.

Authors:  H K Johansen; M Nir; N Høiby; C Koch; M Schwartz
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

8.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

9.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 10.  The spectrum of cystic fibrosis mutations.

Authors:  L C Tsui
Journal:  Trends Genet       Date:  1992-11       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.